Skip to main content
Join the Patient Engagement Forum.Share your experiences by joining our Patient Engagement Forum.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Cataract 38 (CTRCT38) approved 614691
Cataract 39, Multiple Types (CTRCT39) approved 615188
Cataract 4 (CTRCT4) approved 115700
Cataract 40 (CTRCT40) approved 302200
Cataract 44 (CTRCT44) approved 616509
Cataract 6, Multiple Types (CTRCT6) approved 116600
Cataract 9, Multiple Types (CTRCT9) approved 604219
Catecholaminergic Polymorphic Ventricular Tachycardia type 5 with or without muscle weakness (CPVT5) approved 615441
Central Core Disease of Muscle (CCD) approved 117000
Central Hypoventilation Syndrome, Congenital, 1 (CCHS1) approved 209880
Cerebellar Ataxia, Impaired Intellectual Development, and Dysequilibrium Syndrome 1 (CAMRQ1) approved 224050
Cerebellar Ataxia, Impaired Intellectual Development, and Dysequilibrium Syndrome 2 (CAMRQ2) approved 610185
Cerebellar Ataxia, Impaired Intellectual Development, and Dysequilibrium Syndrome 3 (CAMRQ3) approved 613227
Cerebellar Ataxia, Impaired Intellectual Development, and Dysequilibrium Syndrome 4 (CAMRQ4) approved 615268
Cerebral Arteriopathy, Autosomal Dominant, with Subcortical Infarcts and Leukoencephalopathy, Type 1 (CADASIL1) approved 125310
Cerebral Cavernous Malformations (CCM) approved 116860
Cerebral Cavernous Malformations 2 (CCM2) approved 603284
Cerebral Cavernous Malformations 3 (CCM3) approved 603285
Cerebral Creatine Deficiency Syndrome 1 (CCDS1) approved 300352
Cerebral Creatine Deficiency Syndrome 2 (CCDS2) approved 612736